Rating: 4.7 / 5 (1879 votes)
Downloads: 76324
>>>CLICK HERE TO DOWNLOAD<<<
Instructions for use aimovig® ( aim- oh- vig) ( erenumab- aooe) injection, for subcutaneous use single- dose prefilled sureclick® autoinjector 70 mg/ ml this instructions for use contains information on how to inject aimovig. be sure to change the injection site every time. aimovig is intended for patient self- administration. dosage and administration. what you need to know before you use aimovig do not use aimovig - if you are allergic to erenumab or any of the other ingredients of this medicine ( listed in section 6).
please take as directed by your doctor. guide to parts before use after use purple start button expiration date window medicine white cap on. the content of the document is dynamic and will be revised as new information becomes available. some patients may benefit from a dosage of 140 mg injected subcutaneously once monthly. aimovig™ ( erenumab) is indicated pdf for prevention of migraine in adults who have at least 4 migraine days per month. warnings and precautions. aimovigtm ( erenumab- aooe) injection, for subcutaneous use initial u. aimovig ( step therapy) cc, ql emgality 100mg/ ml ( step therapy) cc, ql quliptacc, ql reyvowcc, ql cc, ql vyepticc, ql zavzpretcc, ql anti- migraine agents, triptans naratriptan ( amerge) ql rizatriptan, rizatriptan odt ( maxalt, maxalt mlt) ql sumatriptan nasal, tablets, vial ( imitrex) ql zolmitriptan ( pdf zomig) ql almotriptan ( axert) ql eletriptan ( relpax) ql. 1 dosage the recommended dose of aimovig is 70 mg administered once monthly. these are not all of the possible side effects of aimovig®.
aimovig strengths. aimovig ( erenumab- aooe) injection, for subcutaneous use initial u. • a single- dose prefilled syringe. read it carefully before using aimovig and follow the instructions for use. the active substance in aimovig, erenumab, is a monoclonal antibody ( a type of protein) designed to attach to a receptor ( target) for cgrp on body’ s cells. if aimovig dose is missed, aimovig pdf administer as soon as possible. this pdf is the official label of aimovig, a prescription medicine for the preventive treatment of migraine in adults.
the most common side effects of aimovig® are pain, redness, or swelling at the injection site and constipation. high blood pressure or pdf worsening of high blood pressure can happen after receiving aimovig ®. do not use aimovig® if you are allergic to erenumab- aooe or any ingredients in aimovig. prescribed medicine aimovig® ( erenumab- aooe) patient information please print all information on this form legibly mm dd yyyy patient application page aimovig pdf 1 of 4 insurer name plan name plan phone # - - subscriber name relationship to patient dob /. instructions for use aimovig® ( aim- oh- vig) ( erenumab- aooe) injection, for aimovig pdf subcutaneous use single- dose prefilled syringe 70 mg/ ml and 140 mg/ ml before use guide to parts after use plunger rod. thereafter, aimovig can be scheduled monthly from the date of the last dose. 2 dosage and administration 4. by attaching to this receptor, the medicine stops cgrp from attaching to it and causing migraine. aimovig® copay card terms and conditions. the recommended dosage of aimovig is 70 mg injected subcutaneously once monthly. if you have questions, please callaimovig, monday- friday, 8: 00 am- 9: 00 pm et aimovig pdf for additional support.
aimovig is a preventive medicine for migraine in adults, approved by the european medicines agency. download helpful resources here. • 70 milligrams per 1 milliliter ( mg/ ml) of. aimovig should be initiated by physicians experienced in the diagnosis and treatment of migraine. 2 important administration instructions aimovig is for subcutaneous use only. erenumab- aooe ( aimovig) criteria for use march va pharmacy benefits management services, medical advisory panel, and visn pharmacist executives the following recommendations are based on medical evidence, clinician input, and expert opinion.
aimovig ( erenumab pronounced erenumab- aooe) is an injectable medication pdf that your doctor prescribed for migraine prevention. aimovig is a prescription medicine used to prevent migraine headaches in adults. prior to use, provide proper training to. aimovig is injected into the fatty part of the skin of the belly ( abdomen), thigh, pdf or back of upper arm. please see additional important safety information on the next aimovig pdf page. it contains important information about the dosage, administration, warnings, and side effects of the drug. some patients may benefit from a dosage of 140 mg administered once monthly. read the product information document to learn about its active substance, dosage, benefits, risks and possible side effects. contact your healthcare provider if you have an increase in blood pressure. important safety information who should not use aimovig®?
it contains erenumab- aooe, a monoclonal antibody that blocks a receptor involved in migraine. aimovig is a calcitonin gene- related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. if a dose of aimovig is missed, administer as soon as possible. aimovig® ( erenumab- aooe) is a prescription medicine used for the preventive treatment of migraine in adults.
approval: recent major changes dosage and administration ( 2. how should i take aimovig? if you have further questions, please contact your doctor. 2 important administration. this document provides the full label information for aimovig, including indications, dosage, warnings, and instructions for use. aimovig is indicated for prophylaxis of migraine in adults.
• a single- dose prefilled sureclick auto- injector pen. 70 mg/ ml reference guide 140 mg/ ml pdf reference guide your doctor will walk you through how to inject aimovig, and detailed instructions are provided in the packaging— any information on this website should not replace those instructions. aimovig is used to prevent migraine in adults who have at least 4 migraine days per month when starting treatment with aimovig. approval: indications and usageaimovig is a. see clinical data ( 5. 1 pediatrics pediatrics ( < 18 years of age) : safety and efficacy of aimovig in patients below the age of 18 have not been studied. aimovig is a calcitonin gene- related peptide receptor antagonist indicated for the preventive treatment of migraine in adults ( 1). a chemical messenger called cgrp has been shown to be involved in the development of migraine.
留言列表
